The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >/=7 days after the 2nd dose. Chagla Z. Ann Intern Med 2021 Feb 2. doi: 10.7326/ACPJ202102160.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chagla Z. The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >/=7 days after the 2nd dose. Ann Intern Med 2021 Feb 2. doi: 10.7326/ACPJ202102160.
PMID: 33524290